Icosavax ICVX Stock
15.31 USD
{{ price }}
0.000000%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
NasdaqGS
Market Cap
769.04M USD
LOW - HIGH [24H]
0.0000
-
0.0000 USD
VOLUME [24H]
0 USD
{{ volume }}
P/E Ratio
0
Earnings per share
0 USD
Icosavax Price Chart
Icosavax ICVX Financial and Trading Overview
| Icosavax stock price | 15.31 USD |
| Previous Close | 10.1 USD |
| Open | 10.04 USD |
| Bid | 0 USD x 900 |
| Ask | 0 USD x 800 |
| Day's Range | 8.95 - 10.2 USD |
| 52 Week Range | 2.28 - 16.45 USD |
| Volume | 321.8K USD |
| Avg. Volume | 182.81K USD |
| Market Cap | 372.84M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 23.33 USD |
ICVX Valuation Measures
| Enterprise Value | 230.62M USD |
| Trailing P/E | N/A |
| Forward P/E | -4.30622 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | Infinity |
| Price/Book (mrq) | 1.8598883 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -2.391 |
Trading Information
Icosavax Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 9.89% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 16.45 USD |
| 52 Week Low | 2.28 USD |
| 50-Day Moving Average | 7.69 USD |
| 200-Day Moving Average | 6.49 USD |
ICVX Share Statistics
| Avg. Volume (3 month) | 182.81K USD |
| Avg. Daily Volume (10-Days) | 269.63K USD |
| Shares Outstanding | 41.43M |
| Float | 29.51M |
| Short Ratio | 12.47 |
| % Held by Insiders | 12.10% |
| % Held by Institutions | 81.91% |
| Shares Short | 2.04M |
| Short % of Float | 9.67% |
| Short % of Shares Outstanding | 4.92% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -24.66% |
| Return on Equity (ttm) | -40.37% |
Income Statement
| Revenue (ttm) | 0 USD |
| Revenue Per Share (ttm) | 0 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -96467000 USD |
| Net Income Avi to Common (ttm) | -92786000 USD |
| Diluted EPS (ttm) | -2.3 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 196.59M USD |
| Total Cash Per Share (mrq) | 4.75 USD |
| Total Debt (mrq) | 8.8M USD |
| Total Debt/Equity (mrq) | 4.4 USD |
| Current Ratio (mrq) | 15.671 |
| Book Value Per Share (mrq) | 4.839 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -65864000 USD |
| Levered Free Cash Flow (ttm) | -47719376 USD |
Profile of Icosavax
| Country | United States |
| State | WA |
| City | Seattle |
| Address | 1930 Boren Avenue |
| ZIP | 98101 |
| Phone | 206 737 0085 |
| Website | https://icosavax.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 60 |
Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases through virus-like particle (VLP) platform technology. Its lead product candidate IVX-A12, a respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) VLP vaccine. The company also develops IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical trial; and IVX-241, a vaccine candidate with hMPV target. Icosavax, Inc. was incorporated in 2017 and is headquartered in Seattle, Washington.
Q&A For Icosavax Stock
What is a current ICVX stock price?
Icosavax ICVX stock price today per share is 15.31 USD.
How to purchase Icosavax stock?
You can buy ICVX shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Icosavax?
The stock symbol or ticker of Icosavax is ICVX.
Which industry does the Icosavax company belong to?
The Icosavax industry is Biotechnology.
How many shares does Icosavax have in circulation?
The max supply of Icosavax shares is 50.23M.
What is Icosavax Price to Earnings Ratio (PE Ratio)?
Icosavax PE Ratio is 0.00000000 now.
What was Icosavax earnings per share over the trailing 12 months (TTM)?
Icosavax EPS is 0 USD over the trailing 12 months.
Which sector does the Icosavax company belong to?
The Icosavax sector is Healthcare.
Icosavax ICVX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17366.13 USD — |
-0.1
|
9.58B USD — | 17128.71 USD — | 17467.35 USD — | — - | 9.58B USD — |
| Stlmt ID NASDAQ Biotechnology NBX | 4157.43 USD — |
+0.21
|
— — | 3927.42 USD — | 4157.43 USD — | — - | — — |
| NASDAQ Global Select Market Com NQGS | 8495.19 USD — |
-0.11
|
— — | 8378.66 USD — | 8543.96 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4184.77 USD — |
+1.29
|
— — | 4144.83 USD — | 4202.15 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 931.02 USD — |
+0.81
|
— — | 921.75 USD — | 934.48 USD — | — - | — — |
- {{ link.label }} {{link}}